183 related articles for article (PubMed ID: 32019396)
1. A Critical Discourse Analysis of Intellectual Property Rights Within NAFTA 1.0: Implications for NAFTA 2.0 and for Democratic (Health) Governance in Canada.
Mohamed FA; Chaufan C
Int J Health Serv; 2020 Jul; 50(3):278-291. PubMed ID: 32019396
[TBL] [Abstract][Full Text] [Related]
2. Pharmaceutical patents and some international trade issues: Canada, the United States, and NAFTA.
Tancer RS
Clin Ther; 1993; 15(6):1177-84; discussion 1120. PubMed ID: 8111813
[TBL] [Abstract][Full Text] [Related]
3. USMCA (NAFTA 2.0): tightening the constraints on the right to regulate for public health.
Labonté R; Crosbie E; Gleeson D; McNamara C
Global Health; 2019 May; 15(1):35. PubMed ID: 31088499
[TBL] [Abstract][Full Text] [Related]
4. Trade-Related Aspects of Intellectual Property Rights Flexibilities and Public Health: Implementation of Compulsory Licensing Provisions into National Patent Legislation.
McGIVERN L
Milbank Q; 2023 Dec; 101(4):1280-1303. PubMed ID: 37646392
[TBL] [Abstract][Full Text] [Related]
5. Canada and access to medicines in developing countries: intellectual property rights first.
Lexchin J
Global Health; 2013 Sep; 9():42. PubMed ID: 24007595
[TBL] [Abstract][Full Text] [Related]
6. Intellectual property rights and the Canadian pharmaceutical marketplace: where do we go from here?
Lexchin J
Int J Health Serv; 2005; 35(2):237-56. PubMed ID: 15932005
[TBL] [Abstract][Full Text] [Related]
7. Analyzing the impact of trade and investment agreements on pharmaceutical policy: provisions, pathways and potential impacts.
Gleeson D; Lexchin J; Labonté R; Townsend B; Gagnon MA; Kohler J; Forman L; Shadlen KC
Global Health; 2019 Nov; 15(Suppl 1):78. PubMed ID: 31775767
[TBL] [Abstract][Full Text] [Related]
8. Intellectual property and access to medicines: mapping public attitudes toward pharmaceuticals during the United States-Mexico-Canada Agreement (USMCA) negotiation process.
Wong ASY; Cole CB; Kohler JC
Global Health; 2021 Aug; 17(1):92. PubMed ID: 34416883
[TBL] [Abstract][Full Text] [Related]
9. Realization of the international human right to health in an economically integrated North America.
Kinney ED
J Law Med Ethics; 2009; 37(4):807-18. PubMed ID: 20122127
[TBL] [Abstract][Full Text] [Related]
10. [Evolution of the international intellectual property rights system: patent protection for the pharmaceutical industry and access to medicines].
Chaves GC; Oliveira MA; Hasenclever L; de Melo LM
Cad Saude Publica; 2007 Feb; 23(2):257-67. PubMed ID: 17221075
[TBL] [Abstract][Full Text] [Related]
11. Asserting the primacy of health over patent rights: a comparative study of the processes that led to the use of compulsory licensing in Thailand and Brazil.
Rosenberg ST
Dev World Bioeth; 2014 Aug; 14(2):83-91. PubMed ID: 24750542
[TBL] [Abstract][Full Text] [Related]
12. The politics behind the implementation of the WTO Paragraph 6 Decision in Canada to increase global drug access.
Esmail LC; Kohler JC
Global Health; 2012 Apr; 8():7. PubMed ID: 22472291
[TBL] [Abstract][Full Text] [Related]
13. What is the impact of intellectual property rules on access to medicines? A systematic review.
Tenni B; Moir HVJ; Townsend B; Kilic B; Farrell AM; Keegel T; Gleeson D
Global Health; 2022 Apr; 18(1):40. PubMed ID: 35428250
[TBL] [Abstract][Full Text] [Related]
14. Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?
Oliveira MA; Bermudez JA; Chaves GC; Velásquez G
Bull World Health Organ; 2004 Nov; 82(11):815-21. PubMed ID: 15640916
[TBL] [Abstract][Full Text] [Related]
15. Access to generic antiretrovirals: inequality, intellectual property law, and international trade agreements.
Castro A; Westerhaus M
Cad Saude Publica; 2007; 23 Suppl 1():S85-96. PubMed ID: 17308722
[TBL] [Abstract][Full Text] [Related]
16. NAFTA and occupational health: a Canadian perspective. North American Free Trade Agreement.
Walker C
J Public Health Policy; 1997; 18(3):325-33. PubMed ID: 9360348
[TBL] [Abstract][Full Text] [Related]
17. Consequences of the North American Free Trade Agreement for health services: a perspective from Mexico.
Frenk J; Gómez-Dantés O; Cruz C; Chacón F; Hernández P; Freeman P
Am J Public Health; 1994 Oct; 84(10):1591-7. PubMed ID: 7943476
[TBL] [Abstract][Full Text] [Related]
18. Public health-oriented intellectual property and trade policies in Africa and the regional mechanism under Trade-Related Aspects of Intellectual Property Rights amendment.
Adekola TA
Public Health; 2019 Aug; 173():1-4. PubMed ID: 31203136
[TBL] [Abstract][Full Text] [Related]
19. The trends and constructive ambiguity in international agreements on intellectual property and pharmaceutical affairs: Implications for domestic legislations in low- and middle-income countries.
Son KB; Lee TJ
Glob Public Health; 2018 Sep; 13(9):1169-1178. PubMed ID: 28585477
[TBL] [Abstract][Full Text] [Related]
20. [NAFTA: a challenge and an opportunity for environmental health. The case of the maquila industry].
Espinosa-Torres F; Hernández-Avila M; López-Carrillo L
Salud Publica Mex; 1994; 36(6):597-616. PubMed ID: 7892636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
